Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Oliver Schweika"'
Autor:
Oliver Schweika, Michael Buddensiek, Jürgen Schrader, Thomas Lawo, Andreas Mügge, Leif I. Bösche
Publikováno v:
Pacing and Clinical Electrophysiology. 33:1540-1547
Background: Although a low-energy cardioversion (LEC) shock from an implantable cardioverter-defibrillator (ICD) can terminate ventricular tachycardia (VT), it frequently triggers ventricular fibrillation (VF) and is therefore not used in clinical pr
Autor:
Michael Lippert, Andreas Straub, Stefan Paule, Carsten Stahl, Oliver Schweika, Gerald Czygan, Tim O. Greiner, Karolin Knubben, Klaus Kettering, Volker Kühlkamp, Tobias Walker
Publikováno v:
Pacing and Clinical Electrophysiology. 32:1395-1401
Background: Implantable device diagnostics may play an essential role in simplifying the care of heart failure patients by providing fundamental insights into their complex clinical patterns. Early recognition of heart failure progression by a contin
Autor:
Oliver Schweika, Karolin Knubben, Stefan Paule, Wolfram Beierlein, Carsten Stahl, Tim O. Greiner, Gerald Czygan, Zolt Nagy, Andreas Straub, Michael Lippert, Volker Kühlkamp, Tobias Walker
Publikováno v:
Journal of Cardiovascular Electrophysiology. 18:985-990
Introduction: A large number of heart failure (HF) patients benefit from cardiac resynchronization therapy. Measurements of intrathoracic impedance (ITZ) by implantable devices correlate with intrathoracic fluid content and are used for monitoring lu
Publikováno v:
Europace. 9:812-816
In carriers of dual chamber pacemakers and implantable cardioverter-defibrillators (ICD), detection of atrial fibrillation (AF) is crucial for adequate mode switch function and to avoid inappropriate shock delivery. Detection algorithms rely on the a
Autor:
Thomas, Lawo, Jürgen, Schrader, Michael, Buddensiek, Oliver, Schweika, Andreas, Mügge, Leif I, Bösche
Publikováno v:
Pacing and clinical electrophysiology : PACE. 33(12)
Although a low-energy cardioversion (LEC) shock from an implantable cardioverter-defibrillator (ICD) can terminate ventricular tachycardia (VT), it frequently triggers ventricular fibrillation (VF) and is therefore not used in clinical practice. We t